Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

CategoryBioTech
Employees

Offices

Funding

TOTAL $14M
FUNDING TOTAL $14M
Series A, 4/2012
Astellas Pharma
$14M

Tags

Telsar Pharma

Telsar Pharma Inc., a new company that will develop an Astellas drug for a common inflammatory bowel disease.

Recent Milestones

Videos

Screenshots

Sources

  1. Astellas, biotech VCs to pump $14M into virtual drug developer (fiercebiotech.com) [edit]
Edit This Page
Last Edited 4/27/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy